These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 25048433)

  • 1. Spectrometric characteristics and tumor-affinity of a novel photosensitizer: mono-l-aspartyl aurochlorin e6 (Au-NPe6).
    Ishizumi T; Aizawa K; Tsuchida T; Okunaka T; Kato H
    Photodiagnosis Photodyn Ther; 2004 Dec; 1(4):295-301. PubMed ID: 25048433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Ferrario A; Kessel D; Gomer CJ
    Cancer Res; 1992 May; 52(10):2890-3. PubMed ID: 1581904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model.
    Gomer CJ; Ferrario A
    Cancer Res; 1990 Jul; 50(13):3985-90. PubMed ID: 2354446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces.
    Chan AL; Juarez M; Allen R; Volz W; Albertson T
    Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):72-8. PubMed ID: 15752124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy of intestinal tumors with mono-L-aspartyl chlorin e6 (NPe6): a basic study.
    Kikuchi T; Asakura T; Aihara H; Shiraki M; Takagi S; Kinouchi Y; Aizawa K; Shimosegawa T
    Anticancer Res; 2003; 23(6C):4897-900. PubMed ID: 14981942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mono-L-aspartyl chlorin e6 (NPe6) and hematoporphyrin derivative (HpD) in photodynamic therapy administered to a human cholangiocarcinoma model.
    Wong Kee Song LM; Wang KK; Zinsmeister AR
    Cancer; 1998 Jan; 82(2):421-7. PubMed ID: 9445202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of photodynamic therapy using mono-L-aspartyl chlorin e6 on vessel constriction, vessel leakage, and tumor response.
    McMahon KS; Wieman TJ; Moore PH; Fingar VH
    Cancer Res; 1994 Oct; 54(20):5374-9. PubMed ID: 7923168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study.
    Taber SW; Fingar VH; Coots CT; Wieman TJ
    Clin Cancer Res; 1998 Nov; 4(11):2741-6. PubMed ID: 9829737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of serum on cellular uptake and phototoxicity of mono-L-aspartyl chlorin e6 (NPe6) in vitro.
    Sheyhedin I; Aizawa K; Araake M; Kumasaka H; Okunaka T; Kato H
    Photochem Photobiol; 1998 Jul; 68(1):110-4. PubMed ID: 9679456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
    Spikes JD; Bommer JC
    J Photochem Photobiol B; 1993 Feb; 17(2):135-43. PubMed ID: 8459317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pilot study of topical delivery of mono-L-aspartyl chlorin e6 (NPe6): implication of topical NPe6-photodynamic therapy.
    Wong TW; Aizawa K; Sheyhedin I; Wushur C; Kato H
    J Pharmacol Sci; 2003 Oct; 93(2):136-42. PubMed ID: 14578580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.
    Harvey EH; Webber J; Kessel D; Fromm D
    Am J Surg; 2005 Mar; 189(3):302-5. PubMed ID: 15792755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy with mono-L-aspartyl chlorin e6 can cause necrosis of squamous cell carcinoma of tongue: experimental study on an animal model of nude mouse.
    Kobayashi W; Liu Q; Nakagawa H; Sakaki H; Teh B; Matsumiya T; Yoshida H; Imaizumi T; Satoh K; Kimura H
    Oral Oncol; 2006 Jan; 42(1):46-50. PubMed ID: 16266818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
    Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
    Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase-resolved fluorescence study of mono-L-aspartyl chlorin E6.
    Li L; Kodama K; Saito K; Aizawa K
    J Photochem Photobiol B; 2002 May; 67(1):51-6. PubMed ID: 12007467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation.
    Sheyhedin I; Okunaka T; Kato H; Yamamoto Y; Sakaniwa N; Konaka C; Aizawa K
    Lasers Surg Med; 2000; 26(1):83-9. PubMed ID: 10637007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of GADD-45alpha and VEGF induced tumor recurrence via upregulation of IL-2 after photodynamic therapy using NPe6.
    Ohtani K; Usuda J; Ichinose S; Ishizumi T; Hirata T; Inoue T; Maehara S; Imai K; Kubota M; Tsunoda Y; Yamada M; Tsutsui H; Yamada K; Kuroiwa Y; Furukawa K; Okunaka T; Kato H
    Int J Oncol; 2008 Feb; 32(2):397-403. PubMed ID: 18202762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma.
    Matsumura H; Akimoto J; Haraoka J; Aizawa K
    Lasers Med Sci; 2008 Jul; 23(3):237-45. PubMed ID: 17703335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
    Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy for lung cancers based on novel photodynamic diagnosis using talaporfin sodium (NPe6) and autofluorescence bronchoscopy.
    Usuda J; Tsutsui H; Honda H; Ichinose S; Ishizumi T; Hirata T; Inoue T; Ohtani K; Maehara S; Imai K; Tsunoda Y; Kubota M; Ikeda N; Furukawa K; Okunaka T; Kato H
    Lung Cancer; 2007 Dec; 58(3):317-23. PubMed ID: 17698240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.